HIV-1相关结核及结核免疫重建炎症综合征中的基质降解:一项前瞻性观察研究
该研究在南非开普敦对HIV-1感染与非感染的结核患者及对照进行基质周转的横断面研究,并对有结核免疫重建炎症综合征(TB-IRIS)风险的HIV-1感染结核患者进行前瞻性队列研究。结果显示,HIV-1感染结核患者肺部MMP浓度降低且空洞减少,但血浆PIIINP升高;肺外基质周转升高与TB-IRIS相关,且多西环素可抑制M. tuberculosis诱导的基质降解。
要点
- HIV-1感染结核患者肺部MMP浓度降低,与空洞减少相关。
- HIV-1感染结核患者血浆PIIINP升高,提示肺外基质周转增加。
- 肺外基质周转升高与TB-IRIS发生前及发生时均相关。
核心结论
- 结核中MMP活性因HIV-1状态和 compartment 而异,并释放基质降解产物。
- HIV-1感染患者基质周转在TB-IRIS前及期间均增加,提示新的诊断策略。
- MMP抑制是预防和治疗TB-IRIS的潜在宿主导向治疗策略。
研究设计与样本
- 横断面研究:HIV-1感染和未感染的结核患者及对照的基质周转。
- 前瞻性队列研究:有TB-IRIS风险的HIV-1感染结核患者,地点为南非开普敦。
- 方法包括Luminex定量痰和血浆MMP浓度、ELISA测血浆PIIINP、Alere Determine TB LAM assay测尿LAM,以及体外3D结核肉芽肿模型。
主要发现
- HIV-1感染结核患者较未感染者肺部MMP浓度降低,与空洞减少相关。
- HIV-1感染结核患者血浆PIIINP升高,提示肺外基质周转增加。
- 升高的肺外细胞外基质周转与TB-IRIS相关,无论在TB-IRIS发生前还是发生时。
- 主要胶原酶为MMP-8,可能来源于中性粒细胞并由M. tuberculosis抗原驱动。
- 体外实验中,MMP抑制剂多西环素可抑制M. tuberculosis诱导的基质降解。
临床怎么用
- HIV-1感染结核患者中肺外基质周转标志物(如PIIINP)可能有助于TB-IRIS风险识别。
- MMP抑制(如多西环素)可能作为预防或治疗TB-IRIS的宿主导向策略。
局限性
- 横断面设计无法确定因果关系。
- 体外3D模型结果需临床验证。
- 研究仅在南非开普敦单中心进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extensive immunopathology occurs in human immunodeficiency virus (HIV)/tuberculosis (TB) coinfection, but the underlying molecular mechanisms are not well-defined. Excessive matrix metalloproteinase (MMP) activity is emerging as a key process but has not been systematically studied in HIV-associated TB. METHODS: We performed a cross-sectional study of matrix turnover in HIV type 1 (HIV-1)-infected and -uninfected TB patients and controls, and a prospective cohort study of HIV-1-infected TB patients at risk of TB immune reconstitution inflammatory syndrome (TB-IRIS), in Cape Town, South Africa. Sputum and plasma MMP concentrations were quantified by Luminex, plasma procollagen III N-terminal propeptide (PIIINP) by enzyme-linked immunosorbent assay, and urinary lipoarabinomannan (LAM) by Alere Determine TB LAM assay. Peripheral blood mononuclear cells from healthy donors were cultured with Mycobacterium tuberculosis and extracellular matrix in a 3D model of TB granuloma formation. RESULTS: MMP activity differed between HIV-1-infected and -uninfected TB patients and corresponded with specific TB clinical phenotypes. HIV-1-infected TB patients had reduced pulmonary MMP concentrations, associated with reduced cavitation, but increased plasma PIIINP, compared to HIV-1-uninfected TB patients. Elevated extrapulmonary extracellular matrix turnover was associated with TB-IRIS, both before and during TB-IRIS onset. The predominant collagenase was MMP-8, which was likely neutrophil derived and M. tuberculosis-antigen driven. Mycobacterium tuberculosis-induced matrix degradation was suppressed by the MMP inhibitor doxycycline in vitro. CONCLUSIONS: MMP activity in TB differs by HIV-1 status and compartment, and releases matrix degradation products. Matrix turnover in HIV-1-infected patients is increased before and during TB-IRIS, informing novel diagnostic strategies. MMP inhibition is a potential host-directed therapy strategy for prevention and treatment of TB-IRIS.
引用
- Walker NF, Wilkinson KA, Meintjes G, et al. Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study. Clin Infect Dis. 2017. PMID: 28475709. doi:10.1093/cid/cix231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。